U.S. nears final vaccine review as daily national deaths top 3,250, Facebook hit with antitrust lawsuits, and Florida sheriff deputies deliver meals to kids doing virtual school.
From a Becker’s Hospital Review (BHR) online release article:
10 drugs and medical devices approved by the FDA since Dec. 6:
Enhertuis Japanese drugmaker Daiichi Sankyo’s drug designed to treat HER2-positive breast cancer.
Padcevis Astellas Pharma’s drug designed to target specific cancer cells to treat urothelial cancers.
Control-IQ Technology controlleris Tandem Diabetes Care’s insulin device, designed to help diabetes patients tailor their treatments to their individual needs.
Vascepais Amarin Pharmaceuticals’ drug, a fish oil-derived pill designed to treat cardiovascular events.
EXALT Model Dis Boston Scientific’s device, the first fully disposable duodenoscope, designed to reduce the risk of infections in patients treated with the device.
Vyondys 53 is Sarepta Therapeutics’ drug designed to treat Duchenne muscular dystrophy, which the FDA had previously rejected.
Unidose liquid systemis AptarGroup’s device that uses a nasal spray to treat seizures. It is the first and only nasal treatment for patients with epilepsy.
Avsolais Amgen’s drug, a biosimilar of Johnson & Johnson’s Remicade. It is designed to treat rheumatoid arthritis, Crohn’s disease, plaque psoriasis, psoriatic arthritis and ankylosing spondylitis.
cobas vivoDxis Roche Molecular Systems’ device, designed to diagnose MRSA hours faster than traditional tests.